Respiratory drug sales outpaced overall pharmaceutical market growth in April, driven by seasonal flu, pollution, and rising asthma and COPD cases
Popular Posts
-
India's real estate sentiment slipped into pessimistic territory in Q1 2026 as global uncertainties, rising costs and cautious demand we...
-
Government cuts AGR dues of Vodafone Idea to Rs 64,046 crore, signalling regulatory support, but lack of clarity raises questions on consist...
